-
Natural Compounds Target SARS-CoV-2 Protease: Docking Insigh
2026-07-31
This study leverages molecular docking and dynamics to identify natural compounds, particularly vitamins, as potential inhibitors of the SARS-CoV-2 main protease (3CLpro) and spike protein receptor-binding domain. The findings highlight promising repurposing candidates and inform future antiviral therapeutics research.
-
PBS Liposomes: Mechanistic Controls in Macrophage Depletion
2026-07-30
Explore the advanced role of PBS Liposomes as mechanism-driven controls in macrophage depletion studies. Learn how phosphate-buffered saline liposomes enhance assay precision and interpretability beyond standard controls.
-
Discovery of Potent Cas9 Inhibitors from the Human Microbiom
2026-07-30
Forsberg et al. used functional metagenomics to identify novel anti-CRISPR proteins that inhibit Cas9, notably AcrIIA11 from a Lachnospiraceae phage, highlighting their prevalence and unique mechanisms in the human microbiome. This work advances our understanding of CRISPR-Cas system modulation and provides new tools for genome editing research.
-
VX-765: Selective Caspase-1 Inhibition for Inflammation Mode
2026-07-29
VX-765 empowers researchers to dissect caspase-1 mediated inflammatory responses and pyroptosis with precision, enabling translational workflows in both autoimmunity and infectious disease models. Its oral bioavailability, potent selectivity, and robust performance across primary cell and in vivo systems set a new gold standard for inflammation research.
-
Uridine, Trisodium Salt in PRINT Genome Engineering Workflow
2026-07-29
Uridine, Trisodium Salt elevates RNA-mediated genome editing by providing ultra-high purity and reproducible solubility for demanding workflows like PRINT. Its dual role as an RNA biosynthesis precursor and vascular research tool ensures precise, scalable, and low-toxicity solutions for modern molecular biology.
-
Magnetic Nano-Antibody Enables In Vivo CAR-T-Mimicry for Tum
2026-07-28
This study presents a magnetic bispecific nano-antibody (M-BiNanoAb) platform that programs T cells into CAR-T-mimicking effectors directly in vivo, enabling magnetically guided infiltration and eradication of solid tumors. The approach addresses historic bottlenecks of CAR-T cell therapies in solid cancers by facilitating efficient T cell engineering and tumor targeting without ex vivo manipulation.
-
ECL Western Blotting Substrate: Protocols and Troubleshootin
2026-07-28
The ECL Western Blotting Substrate (SKU K2187) is a chemiluminescent, nonradioactive reagent for detecting horseradish peroxidase (HRP) on immunoblots. It streamlines protein detection workflows in molecular biology, cancer biology, and signal transduction research, but is not suitable for fluorescent or radioisotopic detection applications.
-
Precision Glucose Uptake Analysis: Powering Next-Gen Cancer
2026-07-27
Explore how single-cell metabolic assays like the 2-NBDG Glucose Uptake Assay Kit empower translational researchers to dissect the interplay of glucose and lipid metabolism in cancer therapy resistance, with strategic insights drawn from recent breakthroughs in HCC and ferroptosis.
-
Anlotinib Hydrochloride: Precision Tools for Dissecting Tumo
2026-07-27
Explore the unique pharmacological profile of Anlotinib hydrochloride—a multi-target tyrosine kinase inhibitor—uncovering its unmatched selectivity, pharmacokinetics, and research applications in anti-angiogenic and cancer assays. Gain practical insights beyond standard protocols.
-
Latrunculin B in Viral Entry and Actin Dynamics: Insights fo
2026-07-26
Discover how Latrunculin B enables precision studies of actin cytoskeleton dynamics and informs experimental design for viral entry assays. This article offers a unique, evidence-based perspective on Latrunculin B inhibitor selection, bridging actin research and virological workflows.
-
WP1066, JAK2/STAT3 Inhibitor: Workflow Optimization in Cance
2026-07-25
WP1066 empowers researchers to precisely interrogate the JAK2/STAT3 axis across cancer and regenerative models, streamlining workflows from proliferation assays to advanced tissue scaffolding. Its robust inhibition profile and cell-permeability make it a go-to tool for both tumor suppression and dissecting immune-metabolic crosstalk.
-
WP1066, JAK2/STAT3 Inhibitor: Applied Protocols and Innovati
2026-07-24
WP1066, a potent JAK2/STAT3 inhibitor from APExBIO, empowers cancer, immunology, and regenerative medicine researchers with robust, reproducible tools for pathway dissection and disease modeling. This article unpacks cutting-edge workflows, troubleshooting strategies, and novel applications—bridging oncology with advanced tissue engineering.
-
Q-VD-OPh Pan-Caspase Inhibitor: Protocols, Applications & In
2026-07-24
Q-VD-OPh, a potent pan-caspase inhibitor from APExBIO, empowers apoptosis research with nanomolar precision and broad in vitro/in vivo compatibility. Explore experimental workflows, troubleshooting strategies, and new opportunities inspired by the latest caspase-driven virology breakthroughs.
-
Cisplatin (SKU A8321): Reliable Solutions for Cancer Researc
2026-07-23
Discover how Cisplatin (SKU A8321) from APExBIO addresses key laboratory challenges in cancer research. This article offers scenario-driven guidance for cell viability, apoptosis, and chemotherapy resistance assays, emphasizing reproducibility and validated protocols. Learn how this DNA crosslinking agent supports robust experimental design and data integrity.
-
MMP-2/9-Mediated BBB Disruption in Arsenic-Induced Cognitive
2026-07-23
This study establishes that sodium arsenite induces cognitive deficits in male mice through matrix metalloproteinase-2/9-mediated blood-brain barrier (BBB) disruption and neuronal apoptosis. Doxycycline hyclate, a matrix metalloproteinases inhibitor, effectively preserved BBB integrity and mitigated cognitive impairment, highlighting a mechanistic link and translational target in arsenic neurotoxicity.
444 records 9/30 page Previous Next First page 上5页 678910 下5页 Last page